blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2104669

EP2104669 - INHIBITORS OF AKT ACTIVITY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.08.2015
Database last updated on 19.10.2024
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): MT		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
For all designated states
MSD K.K.
Kitanomaru Square 1-13-12 Kudankita Chiyoda-ku Tokyo
102-8667 / JP
[2014/42]
Former [2012/33]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway NJ 07065-0907 / US
For all designated states
MSD K.K.
Kitanomaru Square 1-13-12 Kudankita Chiyoda-ku Tokyo
102-8667 / JP
Former [2011/11]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
For all designated states
MSD K.K.
Kitanomaru Square 1-13-12 Kudankita Chiyoda-ku Tokyo
102-8667 / JP
Former [2010/10]For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
For all designated states
BANYU PHARMACEUTICAL CO., LTD.
Kitanomaru Square 1-13-12, Kudan-kita Chiyoda-ku
Tokyo 102-8667 / JP
Former [2009/40]For all designated states
Merck & Co., Inc.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
For all designated states
BANYU PHARMACEUTICAL CO., LTD.
Kitanomaru Square 1-13-12, Kudan-kita Chiyoda-ku
Tokyo 102-8667 / JP
Inventor(s)01 / KELLY, Michael J.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
02 / LAYTON, Mark E.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
03 / LIQUORI, Michael E.
1722 Wallace Street
Unit 301
Philadelphia, PA 19130 / US
04 / OGINO, Yoshio
Kitanomaru Square
1-13-12 Kudankita
Chiyoda-ku Tokyo 102-8667 / JP
05 / ONOZAKI, Yu
Kitanomaru Square
1-13-12 Kudankita
Chiyoda-ku Tokyo 102-8667 / JP
06 / SANDERSON, Philip E.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
07 / WANG, Jiabing
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
 [2014/42]
Former [2009/46]01 / KELLY, Michael J.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
02 / LAYTON, Mark E.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
03 / LIQUORI, Michael E.
1722 Wallace Street Unit 301
Philadelphia, PA 19130 / US
04 / OGINO, Yoshio
Kitanomaru Square 1-13-12 Kudankita
Chiyoda-ku Tokyo 102-8667 / JP
05 / ONOZAKI, Yu
Kitanomaru Square 1-13-12 Kudankita
Chiyoda-ku Tokyo 102-8667 / JP
06 / SANDERSON, Philip E.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
07 / WANG, Jiabing
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
Former [2009/40]01 / KELLY, Michael J.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
02 / LAYTON, Mark E.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
03 / LIQUORI, Michael E.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
04 / OGINO, Yoshio
Kitanomaru Square 1-13-12 Kudankita
Chiyoda-ku Tokyo 102-8667 / JP
05 / ONOZAKI, Yu
Kitanomaru Square 1-13-12 Kudankita
Chiyoda-ku Tokyo 102-8667 / JP
06 / SANDERSON, Philip E.
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
07 / WANG, Jiabing
126 East Lincoln Avenue
Rahway, NJ 07065-0907 / US
Representative(s)Buchan, Gavin MacNicol, et al
Merck Sharp & Dohme Limited
European Patent Department
Hertford Road
Hoddesdon
Hertfordshire EN11 9BU / GB
[2014/42]
Former [2009/40]Buchan, Gavin MacNicol, et al
Merck Sharp & Dohme Limited European Patent Department Hertford Road Hoddesdon
Hertfordshire EN11 9BU / GB
Former [2009/37]Buchan, Gavin MacNicol, et al
Merck & Co., Inc. European Patent Department Hertford Road
Hoddesdon, Hertfordshire EN11 9BU / GB
Application number, filing date07862428.503.12.2007
[2009/40]
WO2007US24722
Priority number, dateUS20060873198P06.12.2006         Original published format: US 873198 P
US20070880661P16.01.2007         Original published format: US 880661 P
US20070967872P06.09.2007         Original published format: US 967872 P
[2009/40]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008070016
Date:12.06.2008
Language:EN
[2008/24]
Type: A2 Application without search report 
No.:EP2104669
Date:30.09.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 12.06.2008 takes the place of the publication of the European patent application.
[2009/40]
Type: B1 Patent specification 
No.:EP2104669
Date:15.10.2014
Language:EN
[2014/42]
Search report(s)International search report - published on:EP12.09.2008
ClassificationIPC:C07D401/04, C07D401/06, C07D403/04, C07D403/06, C07D407/04, C07D409/04, C07D413/04, C07D417/04, C07D471/14, A61K31/4353, A61P35/00
[2009/40]
CPC:
C07D401/04 (EP,US); C07D471/04 (KR); A61K31/4353 (KR);
A61P11/06 (EP); A61P17/06 (EP); A61P19/02 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P3/04 (EP); A61P3/10 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P35/04 (EP); A61P37/02 (EP);
A61P37/06 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P9/10 (EP); C07D401/06 (EP,US); C07D403/04 (EP,US);
C07D403/06 (EP,US); C07D407/04 (EP,US); C07D409/04 (EP,US);
C07D413/04 (EP,KR,US); C07D417/04 (EP,US); C07D471/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/40]
Extension statesAL06.07.2009
BA06.07.2009
HR06.07.2009
MK06.07.2009
RS06.07.2009
TitleGerman:HEMMER DER AKT-AKTIVITÄT[2009/40]
English:INHIBITORS OF AKT ACTIVITY[2009/40]
French:INHIBITEURS DE L'ACTIVITÉ AKT[2009/40]
Entry into regional phase06.07.2009National basic fee paid 
06.07.2009Designation fee(s) paid 
06.07.2009Examination fee paid 
Examination procedure03.07.2009Amendment by applicant (claims and/or description)
06.07.2009Examination requested  [2009/40]
22.11.2012Communication of intention to grant the patent
22.03.2013Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
02.04.2013Fee for grant paid
02.04.2013Fee for publishing/printing paid
11.07.2013Communication of intention to grant the patent
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  22.11.2012
Opposition(s)16.07.2015No opposition filed within time limit [2015/39]
Fees paidRenewal fee
07.12.2009Renewal fee patent year 03
22.11.2010Renewal fee patent year 04
07.12.2011Renewal fee patent year 05
07.12.2012Renewal fee patent year 06
06.12.2013Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.12.2007
AT15.10.2014
BG15.10.2014
CY15.10.2014
CZ15.10.2014
DK15.10.2014
EE15.10.2014
FI15.10.2014
LT15.10.2014
LV15.10.2014
MC15.10.2014
MT15.10.2014
PL15.10.2014
RO15.10.2014
SE15.10.2014
SI15.10.2014
SK15.10.2014
IE03.12.2014
LU03.12.2014
BE31.12.2014
GR16.01.2015
IS15.02.2015
PT16.02.2015
[2016/33]
Former [2016/32]HU03.12.2007
AT15.10.2014
BG15.10.2014
CY15.10.2014
CZ15.10.2014
DK15.10.2014
EE15.10.2014
FI15.10.2014
LT15.10.2014
LV15.10.2014
MC15.10.2014
PL15.10.2014
RO15.10.2014
SE15.10.2014
SI15.10.2014
SK15.10.2014
IE03.12.2014
LU03.12.2014
BE31.12.2014
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2016/27]AT15.10.2014
BG15.10.2014
CY15.10.2014
CZ15.10.2014
DK15.10.2014
EE15.10.2014
FI15.10.2014
LT15.10.2014
LV15.10.2014
MC15.10.2014
PL15.10.2014
RO15.10.2014
SE15.10.2014
SI15.10.2014
SK15.10.2014
IE03.12.2014
LU03.12.2014
BE31.12.2014
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2016/25]AT15.10.2014
BG15.10.2014
CY15.10.2014
CZ15.10.2014
DK15.10.2014
EE15.10.2014
FI15.10.2014
LT15.10.2014
LV15.10.2014
PL15.10.2014
RO15.10.2014
SE15.10.2014
SI15.10.2014
SK15.10.2014
IE03.12.2014
LU03.12.2014
BE31.12.2014
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2016/12]AT15.10.2014
CY15.10.2014
CZ15.10.2014
DK15.10.2014
EE15.10.2014
FI15.10.2014
LT15.10.2014
LV15.10.2014
PL15.10.2014
RO15.10.2014
SE15.10.2014
SI15.10.2014
SK15.10.2014
IE03.12.2014
LU03.12.2014
BE31.12.2014
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/46]AT15.10.2014
CY15.10.2014
CZ15.10.2014
DK15.10.2014
EE15.10.2014
FI15.10.2014
LT15.10.2014
LV15.10.2014
PL15.10.2014
RO15.10.2014
SE15.10.2014
SK15.10.2014
IE03.12.2014
LU03.12.2014
BE31.12.2014
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/37]AT15.10.2014
CY15.10.2014
CZ15.10.2014
DK15.10.2014
EE15.10.2014
FI15.10.2014
LT15.10.2014
LV15.10.2014
PL15.10.2014
RO15.10.2014
SE15.10.2014
SK15.10.2014
LU03.12.2014
BE31.12.2014
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/36]AT15.10.2014
CY15.10.2014
CZ15.10.2014
DK15.10.2014
EE15.10.2014
FI15.10.2014
LT15.10.2014
LV15.10.2014
PL15.10.2014
RO15.10.2014
SE15.10.2014
LU03.12.2014
BE31.12.2014
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/35]AT15.10.2014
CY15.10.2014
DK15.10.2014
EE15.10.2014
FI15.10.2014
LT15.10.2014
LV15.10.2014
PL15.10.2014
SE15.10.2014
LU03.12.2014
BE31.12.2014
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/30]AT15.10.2014
CY15.10.2014
FI15.10.2014
LT15.10.2014
LV15.10.2014
PL15.10.2014
SE15.10.2014
BE31.12.2014
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/26]AT15.10.2014
CY15.10.2014
FI15.10.2014
LT15.10.2014
LV15.10.2014
PL15.10.2014
SE15.10.2014
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/25]AT15.10.2014
FI15.10.2014
LT15.10.2014
LV15.10.2014
PL15.10.2014
SE15.10.2014
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/24]FI15.10.2014
LT15.10.2014
LV15.10.2014
PL15.10.2014
SE15.10.2014
GR16.01.2015
IS15.02.2015
PT16.02.2015
Former [2015/23]FI15.10.2014
LT15.10.2014
IS15.02.2015
PT16.02.2015
Former [2015/22]LT15.10.2014
PT16.02.2015
Former [2015/20]LT15.10.2014
Cited inInternational search[A]WO2004096130  (MERCK & CO INC [US], et al) [A] 1-16 * pages 1,35; compound 1.7 *;
 [A]WO2006036395  (MERCK & CO INC [US], et al) [A] 1-16 * pages 1,50; compound 1.5 *;
 [A]EP1679308  (UBE INDUSTRIES [JP], et al) [A] 1-16* page 14, paragraph 3 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.